Found 36 matching trials
Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors PHASE1 This is a Phase 1 study of central nervous system (CNS) locoregional adopti...
Show More Status
Active Not Recruiting
Location
Seattle Children's Hospital
Learn More & Join Trial
Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors PHASE1 This is a single-arm, open-label, Phase I study to evaluate the safety, tol...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) PHASE1 This is a phase I dose-escalation study to determine the safety and feasibi...
Show More Location
Children's National Hospital
Learn More & Join Trial
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors PHASE1 This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian PHASE1 This is single center, open-label phase 1 dose escalation trial that uses m...
Show More Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center
Learn More & Join Trial
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma PHASE1 The purpose of this clinical trial is to assess the feasibility, safety and...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma PHASE2 The purpose of this study is to assess the safety, feasibility, and effecti...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors PHASE1 The purpose of this study is to test the manufacturing feasibility and safe...
Show More Location
Stanford University
Learn More & Join Trial
Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma. PHASE1 This is a phase I, open-Label, single/multiple dose, dose-escalation study ...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc PHASE1 The purpose of this study is to test the safety of using T lymphocyte chime...
Show More Location
Lineberger Comprehensive Cancer Center
Learn More & Join Trial